The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.0M data for 1.3M Compounds and 9.6K Targets. Of those, 1.5M data for 695K Compounds and 4.7K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

Advanced Search

18 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Data
Article Title
Organization
Identification of human telomerase inhibitors having the core of N-acyl-4,5-dihydropyrazole with anticancer effects.EBI
Hefei University of Technology
Novel 2H-chromen-2-one derivatives of resveratrol: Design, synthesis, modeling and use as human monoamine oxidase inhibitors.EBI
Hefei University of Technology
Synthesis and biological evaluation of some novel resveratrol amide derivatives as potential anti-tumor agents.EBI
Hefei University of Technology
Factor XIa Inhibitors in Anticoagulation Therapy: Recent Advances and Perspectives.EBI
Hefei University of Technology
Discovery and development of plasma kallikrein inhibitors for multiple diseases.EBI
Hefei University of Technology
Zinc enzymes in medicinal chemistry.EBI
Hefei University of Technology
Small-Molecule Kinase Inhibitors for the Treatment of Nononcologic Diseases.EBI
Hefei University of Technology
Lessons Learned from Past Cyclin-Dependent Kinase Drug Discovery Efforts.EBI
Hefei University of Technology
Targeting the S2 Subsite Enables the Structure-Based Discovery of Novel Highly Selective Factor XIa Inhibitors.EBI
Hefei University of Technology
Novel 1-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-indene-4-thiol derivatives as potent selective human monoamine oxidase B inhibitors: Design, SAR development, and biological evaluation.EBI
Hefei University of Technology
Design, synthesis and anticancer activities of novel dual poly(ADP-ribose) polymerase-1/histone deacetylase-1 inhibitors.EBI
Hefei University of Technology
Structure-based design and SAR development of novel selective polo-like kinase 1 inhibitors having the tetrahydropteridin scaffold.EBI
Hefei University of Technology
Design, synthesis and biological evaluation of novel human monoamine oxidase B inhibitors based on a fragment in an X-ray crystal structure.EBI
Hefei University of Technology
Discovery of novel 2,3-dihydro-1H-inden-1-amine derivatives as selective monoamine oxidase B inhibitors.EBI
Hefei University of Technology
Homoisoflavonoids as potential imaging agents for β-amyloid plaques in Alzheimer's disease.EBI
Hefei University of Technology
The selectivity and bioavailability improvement of novel oral anticoagulants: An overview.EBI
Hefei University of Technology
Design, synthesis and bioevalucation of novel 2,3-dihydro-1H-inden-1-amine derivatives as potent and selective human monoamine oxidase B inhibitors based on rasagiline.EBI
Hefei University of Technology
Design, synthesis, and biological evaluation of novel highly selective polo-like kinase 2 inhibitors based on the tetrahydropteridin chemical scaffold.EBI
Hefei University of Technology